News
A new bill could make the price of prescription drugs known for weight loss cheaper for the state to buy for its employees. The bill would eliminate pharmacy benefit ...
A bill would allow Ohio state employees to purchase GLP-1s from manufacturers, then would require the Department of ...
With Novo Nordisk’s Wegovy already in the market, Eli Lilly is stepping up its game with a patient-friendly pen device, ...
A separate Prime analysis, however, of year-over-year claims data for Wegovy and Zepbound only found an improvement in ...
It would behoove more Americans to learn how consistent seafood consumption has strong potential to ward off coronary disease ...
If you or your family and friends take some weight loss medications, you'll want to read this. Some users are reporting ...
(Reuters) -India’s drug regulator on Thursday approved the launch of pre-filled injector pens of Eli Lilly (NYSE: LLY )’s ...
StockStory.org on MSN3h
Why Is Hims & Hers Health (HIMS) Stock Soaring TodayWhat Happened? Shares of telehealth company Hims & Hers Health (NYSE:HIMS) jumped 12.1% in the afternoon session after the ...
Uninsured or self-pay obesity patients can get any dose of Wegovy for $299 from July 1–31, 2025. Patients can get their ...
Novo Nordisk continues to expand its partnerships with telehealth companies to broaden access to its blockbuster weight loss ...
Novo Nordisk said on Thursday it will collaborate with WeightWatchers to sell its blockbuster weight-loss drug Wegovy, ...
Weight loss and diabetes jabs taken by more than a million people in the UK have been linked to a potential serious side effect, with some deaths, according to data from the UK medicines regulator.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results